Chemo Safety: Can Biomarkers Help?
Dr. David Kerr reports on 'toxgnostics,' the use of genetic markers to identify patients at high risk for adverse side effects from chemotherapy and logically modify doses before treatment (Source: Medscape Oncology)
Source: Medscape Oncology - August 28, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Kiss of Death for Cancer Research?
Dr. David Kerr comments on an ESMO position paper reporting that unintended consequences of the European Union's proposed law on data protection may seriously hinder cancer research. (Source: Medscape Oncology)
Source: Medscape Oncology - August 25, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
CLL's 'Very Unusual Year'
Dr. Bruce Cheson discusses how to choose among the new, exciting options available for the treatment of chronic lymphocytic leukemia: obinutuzumab, ibrutinib, and idelalisib. (Source: Medscape Oncology)
Source: Medscape Oncology - August 20, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is Fast MRI Better Than Mammography?
Dr. Kathy Miller reports on a study showing 'fast' MRI is faster, cheaper, and more accurate than conventional MRI, and is better than mammography for screening certain women for breast cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - August 18, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Prostate Cancer Survivors Need Well-Rounded Care
Dr. Gerald Chodak discusses a new report from the American Cancer Society that provides guidance on long-term care for men who have been diagnosed with prostate cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - August 14, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Physician Approaches to Prostate Cancer Vary Widely
Dr. Gerald Chodak asks how clinicians can provide a more standardized approach to low-risk prostate cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - August 12, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
New Agents Topple Resistance in NSCLC
Dr. Mark Kris reports on new agents that overcome acquired resistance to EGFR TKIs in patients with NSCLC who have a T790 mutation, and recommends rebiopsying patients to identify who would benefit. (Source: Medscape Oncology)
Source: Medscape Oncology - August 11, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
HIFU for Prostate Cancer: Efficacy Data 'Lacking'
Dr. Gerald Chodak discusses an FDA panel's recent recommendation against approving high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - August 11, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
PSA Discoverer Says Antigen Test Is Misused, Unreliable
Are you still doing routine PSA screening? The man who discovered the antigen questions the test's validity. (Source: Medscape Oncology)
Source: Medscape Oncology - August 8, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
A Physician's Perspective on Assisted Suicide
Dr. David Kerr thoughtfully responds to news that religious leaders support a proposed UK law for physician-assisted suicide and ponders whether he could offer his cancer patients this option. (Source: Medscape Oncology)
Source: Medscape Oncology - August 7, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Cancer Risk Arithmetic: 25 x 25 = 37M
Dr. David Kerr reports that a 25% reduction in risk factors for noncommunicable diseases by 2025 could save 37 million lives, and urges physicians to work harder to help patients give up tobacco. (Source: Medscape Oncology)
Source: Medscape Oncology - August 4, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Why Don't CRC Survival Data Add Up?
Dr. John Marshall questions why the survival rate in a large phase 3 trial presented at ASCO was nearly double the survival rates achieved by earlier trials while using the same medicines. (Source: Medscape Oncology)
Source: Medscape Oncology - August 4, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
USPSTF: Prostate Cancer Screening Gets a 'D'
Dr. Gerald Chodak reviews the final guidance from the US Preventive Services Task Force on prostate cancer screening. (Source: Medscape Oncology)
Source: Medscape Oncology - July 31, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
The Molecular Tumor Board
Dr. Maurie Markman discusses the potential of 'molecular tumor boards' to interpret the genomic and genetic test results of cancer patients who do not have clear treatment options. (Source: Medscape Oncology)
Source: Medscape Oncology - July 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Reducing Patients' Symptom Burden in Cancer
Dr. Maurie Markman discusses the clinical importance of reducing ovarian cancer patients' symptoms, even when they do not clearly respond to treatment using typical measures like RECIST. (Source: Medscape Oncology)
Source: Medscape Oncology - July 18, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
